The NOS/sGC pathway in the rat central nervous system: a microdialysis overview

It is now well established that nitric oxide is involved in a variety of physiopathological processes in the central nervous system, which mainly result from the interaction of this gaseous molecule with the heme group of soluble guanylyl cyclase and the elevation of intracellular cGMP in target neurons. During the last decade, several studies have monitored extracellular cGMP, by means of intracerebral microdialysis, to investigate in vivo the functioning and modulation of this neurochemical pathway under different experimental conditions and in various brain regions. In this review, we summarise some of the most relevant results obtained in this research field.

[1]  R. Gray,et al.  Hippocampal synaptic transmission enhanced by low concentrations of nicotine , 1996, Nature.

[2]  G. Divincenzo,et al.  The enlarging view of hexacarbon neurotoxicity. , 1980, Critical reviews in toxicology.

[3]  M. Zarrindast,et al.  Effects of nicotine on memory retrieval in mice. , 1996, European journal of pharmacology.

[4]  K. Kendrick,et al.  Formation of olfactory memories mediated by nitric oxide , 1997, Nature.

[5]  S. Kalra,et al.  Diurnal rhythm in cyclic GMP/nitric oxide efflux in the medial preoptic area of male rats , 1998, Brain Research.

[6]  R. Busto,et al.  Ischemia-induced changes in extracellular levels of striatal cyclic GMP: role of nitric oxide , 1995, Neuroreport.

[7]  J. Hirrlinger,et al.  Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones , 2002, Journal of neurochemistry.

[8]  A. Guidotti,et al.  The activation of inositol phospholipid metabolism as a signal- transducing system for excitatory amino acids in primary cultures of cerebellar granule cells , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[9]  S. Snyder,et al.  Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[10]  J. Laitinen,et al.  Regulation of cyclic GMP levels in the rat frontal cortex in vivo: effects of exogenous carbon monoxide and phosphodiesterase inhibition , 1997, Brain Research.

[11]  E. Fedele,et al.  Nicotine administration stimulates the in vivo N‐methyl‐D‐aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release , 1998, British journal of pharmacology.

[12]  E. Fedele,et al.  Intracerebral administration of l-kynurenine decreases N-methyl-d-aspartate receptor-mediated production of cGMP in the cerebellum and hippocampus of unanaesthetized rats subjected to transcerebral microdialysis , 1999, Neuroscience Letters.

[13]  Zhe-Sheng Chen,et al.  Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. , 2001, The Journal of biological chemistry.

[14]  J. Foncin.  Alzheimer's disease and aluminium , 1987, Nature.

[15]  E X Albuquerque,et al.  Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. , 1997, The Journal of pharmacology and experimental therapeutics.

[16]  A. Donoso,et al.  Glutamate receptors of the non-N-methyl-D-aspartic acid type mediate the increase in luteinizing hormone-releasing hormone release by excitatory amino acids in vitro. , 1990, Endocrinology.

[17]  Edward D. Levin,et al.  Nicotinic systems and cognitive function , 2005, Psychopharmacology.

[18]  J. Burgunder,et al.  Expression of Soluble Guanylyl Cyclase Gene in Adult Rat Brain , 1994, The European journal of neuroscience.

[19]  K. Reymann,et al.  Aluminum Impairs Hippocampal Long-Term Potentiation in Rats in Vitro and in Vivo , 1995, Experimental Neurology.

[20]  Richard J Weinberg,et al.  Synaptic Localization of Nitric Oxide Synthase and Soluble Guanylyl Cyclase in the Hippocampus , 2002, The Journal of Neuroscience.

[21]  S. Arneric,et al.  Effects of lobeline, a nicotinic receptor agonist, on learning and memory , 1993, Pharmacology Biochemistry and Behavior.

[22]  S H Snyder,et al.  Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  S. Heinemann,et al.  Cloned glutamate receptors. , 1994, Annual review of neuroscience.

[24]  D. Luo,et al.  Metalloporphyrins inhibit nitric oxide-dependent cGMP formation in vivo. , 1994, European journal of pharmacology.

[25]  H. Davson,et al.  THE CONCENTRATIONS OF FREE AMINO ACIDS AND OTHER ELECTROLYTES IN CEREBROSPINAL FLUID, IN VIVO DIALYSATE OF BRAIN, AND BLOOD PLASMA OF THE DOG * , 1966, Journal of neurochemistry.

[26]  J. Garthwaite,et al.  Glutamate as the Principal Mossy Fibre Transmitter in Rat Cerebellum: pharmacological evidence , 1990, The European journal of neuroscience.

[27]  P. Whitehouse,et al.  Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications. , 1995, Alzheimer disease and associated disorders.

[28]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[29]  G. Reid,et al.  Therapeutic and biological importance of getting nucleotides out of cells: a case for the ABC transporters, MRP4 and 5. , 2002, Advanced drug delivery reviews.

[30]  P. Seeburg.  The TINS/TiPS Lecture the molecular biology of mammalian glutamate receptor channels , 1993, Trends in Neurosciences.

[31]  V. Felipo,et al.  Chronic Exposure to Aluminum Impairs Neuronal Glutamate‐Nitric Oxide‐Cyclic GMP Pathway , 1998, Journal of neurochemistry.

[32]  L. Role,et al.  Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. , 1995, Science.

[33]  V. Felipo,et al.  Activation of N‐methyl‐D‐aspartate receptors in rat brain in vivo following acute ammonia intoxication: Characterization by in vivo brain microdialysis , 2000, Hepatology.

[34]  T. Bártfai,et al.  Galanin stimulates the N-methyl-d-aspartate receptor/nitric oxide/cyclic GMP pathway in vivo in the rat ventral hippocampus , 1998, Neuroscience.

[35]  V. Felipo,et al.  Chronic exposure to aluminium impairs the glutamate-nitric oxide-cyclic GMP pathway in the rat in vivo , 1999, Neurochemistry International.

[36]  R. Nicoll,et al.  Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus. , 1989, European journal of pharmacology.

[37]  S. Heinemann,et al.  Domains involved in the specificity of G protein activation in phospholipase C‐coupled metabotropic glutamate receptors. , 1994, The EMBO journal.

[38]  E. Fedele,et al.  Benzodiazepine‐Sensitive GABAA Receptors Limit the Activity of the NMDA/NO/Cyclic GMP Pathway , 2000 .

[39]  S. Kalra,et al.  Evidence that gonadal steroids modulate nitric oxide efflux in the medial preoptic area: effects of N-methyl-D-aspartate and correlation with luteinizing hormone secretion. , 1996, Endocrinology.

[40]  D. Perl,et al.  Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study , 1992, Annals of neurology.

[41]  I. Matsuoka,et al.  Localization of adenylyl and guanylyl cyclase in rat brain by in situ hybridization: comparison with calmodulin mRNA distribution , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  G. Fisone,et al.  Galanin Reduces Carbachol Stimulation of Phosphoinositide Turnover in Rat Ventral Hippocampus by Lowering Ca2+ Influx Through Voltage‐Sensitive Ca2+ Channels , 1991, Journal of neurochemistry.

[43]  G. Divincenzo,et al.  The relative neurotoxicity of methyl-n-butyl ketone, n-hexane and their metabolites. , 1980, Toxicology and applied pharmacology.

[44]  A. Davison,et al.  Selective inhibition of L-glutamate and gammaaminobutyrate transport in nerve ending particles by aluminium, manganese, and cadmium chloride. , 1981, Journal of inorganic biochemistry.

[45]  S. Kalra,et al.  Ovarian Steroid‐Independent Diurnal Rhythm in Cyclic GMP/Nitric Oxide Efflux in the Medial Preoptic Area: Possible Role in Preovulatory and Ovarian Steroid‐Induced LH Surge* , 1998, Journal of neuroendocrinology.

[46]  E. Fedele,et al.  Desensitization of AMPA receptors and AMPA‐NMDA receptor interaction: an in vivo cyclic GMP microdialysis study in rat cerebellum , 1996, British journal of pharmacology.

[47]  J. Zwiller,et al.  Immunohistochemical localization of guanylate cyclase in rat cerebellum. , 1981, Neuroscience letters.

[48]  Zhe-Sheng Chen,et al.  MRP8, ATP-binding Cassette C11 (ABCC11), Is a Cyclic Nucleotide Efflux Pump and a Resistance Factor for Fluoropyrimidines 2′,3′-Dideoxycytidine and 9′-(2′-Phosphonylmethoxyethyl)adenine* , 2003, Journal of Biological Chemistry.

[49]  M. Tjörnhammar,et al.  Efflux of cyclic guanosine 3′,5′-monophosphate from cerebellar slices stimulated by l-glutamate or high K+ or N-methyl-N′-nitro-N-nitrosoguanidine , 1986, Neuroscience Letters.

[50]  M. Raiteri,et al.  Monitoring of cyclic GMP during cerebellar microdialysis in freely-moving rats as an index of nitric oxide synthase activity , 1993, Neuroscience.

[51]  M. Roisin,et al.  Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus. , 1993, European journal of pharmacology.

[52]  V. Felipo,et al.  Altered content and modulation of soluble guanylate cyclase in the cerebellum of rats with portacaval anastomosis , 2001, Neuroscience.

[53]  L. A. Bates,et al.  Neurotoxicity of Aluminum , 1984 .

[54]  M. A. Ariano,et al.  Immunohistochemical localization of guanylate cyclase within neurons of rat brain. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[55]  S. Palay,et al.  The Cerebellum—New Vistas , 1982 .

[56]  K. Kuriyama,et al.  Activation of cerebral guanylate cyclase by nitric oxide. , 1977, Biochemical and biophysical research communications.

[57]  E. Fedele,et al.  GABAA, but not NMDA, receptors modulate in vivo NO-mediated cGMP synthesis in the rat cerebral cortex , 2004, Neuropharmacology.

[58]  D. Keppler,et al.  The Multidrug Resistance Protein 5 Functions as an ATP-dependent Export Pump for Cyclic Nucleotides* , 2000, The Journal of Biological Chemistry.

[59]  M. Verity,et al.  Mineral and Metal Neurotoxicology , 1996 .

[60]  Y. Kitamura,et al.  Mechanism of selective motor neuronal death after exposure of spinal cord to glutamate: Involvement of glutamate‐induced nitric oxide in motor neuron toxicity and nonmotor neuron protection , 1998, Annals of neurology.

[61]  J. Canales,et al.  Chronic exposure to 2,5-hexanedione impairs the glutamate-nitric oxide-cyclic GMP pathway in cerebellar neurons in culture and in rat brain in vivo , 2003, Neurochemistry International.

[62]  H. Endou,et al.  The multispecific organic anion transporter (OAT) family , 2000, Pflügers Archiv.

[63]  B. Westerink,et al.  Brain microdialysis of GABA and glutamate: What does it signify? , 1997, Synapse.

[64]  E. Fedele,et al.  In vivo microdialysis study of GABAA and GABaB receptors modulating the glutamate receptor/NO/ cyclic GMP pathway in the rat hippocampus , 1997, Neuropharmacology.

[65]  E. Fedele,et al.  D-serine modulates the NMDA receptor/nitric oxide/cGMP pathway in the rat cerebellum during in vivo microdialysis , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

[66]  J. Laitinen,et al.  A sensitive microassay reveals marked regional differences in the capacity of rat brain to generate carbon monoxide , 1995, Brain Research.

[67]  T. Dawson,et al.  Manganese Superoxide Dismutase Protects nNOS Neurons from NMDA and Nitric Oxide-Mediated Neurotoxicity , 1998, The Journal of Neuroscience.

[68]  Gordon M. Shepherd,et al.  Implications of the NO/cGMP system for olfaction , 1993, Trends in Neurosciences.

[69]  R. Weinberg,et al.  Neurons in rat hippocampus that synthesize nitric oxide , 1993, The Journal of comparative neurology.

[70]  J. Garthwaite,et al.  Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain , 1988, Nature.

[71]  D. Warburton,et al.  Nicotine as a cognitive enhancer , 1992, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[72]  K. Aguan,et al.  Histochemical localization of nitric oxide neurons in the hypothalamus: association with gonadotropin-releasing hormone neurons and co-localization with N-methyl-D-aspartate receptors. , 1995, Neuroendocrinology.

[73]  J. Jhamandas,et al.  Novel excitatory actions of galanin on rat cholinergic basal forebrain neurons: implications for its role in Alzheimer's disease. , 2002, Journal of neurophysiology.

[74]  E. Leung,et al.  Nitric oxide-dependent efflux of cGMP in rat cerebellar cortex: an in vivo microdialysis study , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[75]  H. Schulman,et al.  Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins , 1994, Neuron.

[76]  E. Fedele,et al.  In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway , 1996, British journal of pharmacology.

[77]  Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. , 2002 .

[78]  T. Hökfelt,et al.  Functional aspects of acetylcholine-galanin coexistence in the brain. , 1990, Progress in brain research.

[79]  G. Drummond,et al.  Prevention of neonatal hyperbilirubinemia by tin protoporphyrin IX, a potent competitive inhibitor of heme oxidation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[80]  J. Garthwaite,et al.  Sources and targets of nitric oxide in rat cerebellum , 1992, Neuroscience Letters.

[81]  D. Smith,et al.  Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[82]  V. Chan‐Palay.  Neurotransmitters and Receptors in the Cerebellum: Immunocytochemical Localization of Glutamic Acid Decarboxylase, GABA-Transaminase, and Cyclic GMP and Autoradiography with 3H-Muscimol , 1982 .

[83]  M. Moretto,et al.  Nitric oxide regulates luteinizing hormone-releasing hormone secretion. , 1993, Endocrinology.

[84]  Y. Agid,et al.  Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray Microanalysis , 1991, Journal of neurochemistry.

[85]  P. Greengard,et al.  Immunohistochemical localization of cyclic GMP-dependent protein kinase in mammalian brain. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[86]  E. Fedele,et al.  The glutamate receptor/no/cyclic gmp pathway in the hippocampus of freely moving rats: Modulation by cyclothiazide, interaction with gaba and the behavioural consequences , 1997, Neuropharmacology.

[87]  H. Kimura,et al.  Histochemical mapping of nitric oxide synthase in the rat brain , 1992, Neuroscience.

[88]  M. Raiteri,et al.  Extracellular cGMP in the hippocampus of freely moving rats as an index of nitric oxide (NO) synthase activity , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[89]  E. Anderzhanova,et al.  Taurine reduces ammonia- and N-methyl-D-aspartate-induced accumulation of cyclic GMP and hydroxyl radicals in microdialysates of the rat striatum. , 2003, European journal of pharmacology.

[90]  S. Nakanishi,et al.  Sequence and expression of a metabotropic glutamate receptor , 1991, Nature.

[91]  M. Ichikawa,et al.  Light and electron microscopic demonstration of guanylate cyclase in rat brain , 1983, Brain Research.

[92]  J. Laitinen,et al.  Differential regulation of cyclic GMP levels in the frontal cortex and the cerebellum of anesthetized rats by nitric oxide: an in vivo microdialysis study , 1994, Brain Research.

[93]  H. Haas,et al.  Aluminium reduces glutamate-activated currents of rat hippocampal neurones. , 1994, Neuroreport.

[94]  R. Yokel,et al.  Aluminum inhibits glutamate release from transverse rat hippocampal slices: role of G proteins, Ca channels and protein kinase C. , 1992, Neurotoxicology.

[95]  V. Felipo,et al.  Chronic hyperammonemia impairs the glutamate–nitric oxide–cyclic GMP pathway in cerebellar neurons in culture and in the rat in vivo , 1998, The European journal of neuroscience.

[96]  S. Kalra,et al.  Evidence that nitric oxide may mediate the ovarian steroid-induced luteinizing hormone surge: involvement of excitatory amino acids. , 1993, Endocrinology.

[97]  J. Garthwaite,et al.  Vicious Cycle Involving Na+ Channels, Glutamate Release, and NMDA Receptors Mediates Delayed Neurodegeneration through Nitric Oxide Formation , 1996, The Journal of Neuroscience.

[98]  J. Garthwaite,et al.  The nitric oxide-cyclic GMP signalling pathway in rat brain , 1993, Neuropharmacology.

[99]  J. McCarten,et al.  Nicotine patches in Alzheimer's disease: Pilot study on learning, memory, and safety , 1995, Pharmacology Biochemistry and Behavior.

[100]  T. Svensson,et al.  Effects of acute and chronic electroconvulsive stimuli on cAMP and cGMP efflux in the rat striatum and hippocampus , 2000, European Neuropsychopharmacology.

[101]  C. Gardner,et al.  Receptor sub-types involved in responses of purkinje cell to exogenous excitatory amino acids and local electrical stimulation in cerebellar slices in the rat , 1991, Neuropharmacology.

[102]  E. Fedele,et al.  In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway , 1999, Progress in Neurobiology.

[103]  U. Ungerstedt,et al.  Dopamine neurotransmission and brain function. , 1982, Progress in brain research.

[104]  R. Tsien,et al.  Existence of nitric oxide synthase in rat hippocampal pyramidal cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[105]  L. Ignarro,et al.  Regulation of soluble guanylate cyclase activity by porphyrins and metalloporphyrins. , 1984, The Journal of biological chemistry.

[106]  P. Greengard,et al.  Anatomy of cerebellar Purkinje cells in the rat determined by a specific immunohistochemical marker , 1984, Neuroscience.

[107]  T. Dawson,et al.  Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[108]  P. Greengard,et al.  Localization of cyclic GMP-dependent protein kinase and substrate in mammalian cerebellum. , 1980, Proceedings of the National Academy of Sciences of the United States of America.